P B Hylemon
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- RNA and protein synthesis mechanisms 2
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
- Co-authors
- Jens Harder (1 shared paper)Rashmi Gopal-Srivastava (1 shared paper)Z.R. Vlahcevic (6 shared papers)W B White (3 shared papers)Emily C. Gurley (5 shared papers)R. Todd Stravitz (4 shared papers)Darrell H. Mallonee (1 shared paper)Babiker M. A. Abdel‐Banat (1 shared paper)
- Journals
- Journal of Lipid Research (5 papers)Journal of Bacteriology (3 papers)Journal of Biological Chemistry (2 papers)Applied and Environmental Microbiology (2 papers)Protein Expression and Purification (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
P B Hylemon
21 papers receiving 889 citations
Peers
Comparison fields: 5 of 84
- Oncology 405
- Pharmacology 98
- Clinical Biochemistry 51
- Molecular Biology 460
- Surgery 251
Countries citing papers authored by P B Hylemon
This map shows the geographic impact of P B Hylemon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P B Hylemon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P B Hylemon more than expected).
Fields of papers citing papers by P B Hylemon
This network shows the impact of papers produced by P B Hylemon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P B Hylemon. The network helps show where P B Hylemon may publish in the future.
Co-authors
The 25 scholars most cited alongside P B Hylemon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 127 | |
| 2 | 1980 | 110 | |
| 3 | 1988 | 108 | |
| 4 | 1990 | 93 | |
| 5 | 1996 | 91 | |
| 6 | 1997 | 72 | |
| 7 | 1985 | 58 | |
| 8 | 1997 | 55 | |
| 9 | 1991 | 39 | |
| 10 | 1980 | 35 | |
| 11 | 1986 | 31 | |
| 12 | 1988 | 24 | |
| 13 | 1987 | 22 | |
| 14 | 1988 | 22 | |
| 15 | Cultured human gallbladder epithelia. Methods and partial characterization of a carcinoma-derived model. | 1993 | 21 |
| 16 | 1984 | 17 | |
| 17 | Molecular genetics and regulation of bile acid biosynthesis. | 1994 | 7 |
| 18 | 1992 | 6 | |
| 19 | 1991 | 5 | |
| 20 | 1991 | 4 |
About P B Hylemon
P B Hylemon is a scholar working on Molecular Biology, Oncology, Genetics, Surgery and Pharmacology, having authored 21 papers that have together received 949 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Bacterial Genetics and Biotechnology (5 papers), Cholesterol and Lipid Metabolism (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Enzyme Structure and Function (3 papers), Aldose Reductase and Taurine (2 papers), Hormonal Regulation and Hypertension (2 papers) and RNA and protein synthesis mechanisms (2 papers). The work is most often cited by research in Oncology (405 citations), Pharmacology (98 citations), Clinical Biochemistry (51 citations), Molecular Biology (460 citations) and Surgery (251 citations). P B Hylemon has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Jens Harder, Rashmi Gopal-Srivastava, Z.R. Vlahcevic, W B White, Emily C. Gurley, R. Todd Stravitz, Darrell H. Mallonee, Babiker M. A. Abdel‐Banat, Yi-Ping Rao and W. Michael Holmes. Their work appears in journals such as Journal of Lipid Research, Journal of Bacteriology, Journal of Biological Chemistry, Applied and Environmental Microbiology and Protein Expression and Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.